Differential effects of systemic insulin delivery and prednisone on tissue glucose and insulin sensitivity in insulin-dependent diabetes mellitus pancreas recipients.
Osei
K
K
Department of Internal Medicine, Ohio State University Hospitals, Columbus.
Henry
M
M
Ferguson
R
R
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000503:physiopathology* / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000097:blood / Q000601:surgery; D005260:Female; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D016030:Kidney Transplantation / Q000502:physiology; D007700:Kinetics; D008297:Male; D016035:Pancreas Transplantation / Q000502:physiology*; D011241:Prednisone / Q000494:pharmacology* / Q000627:therapeutic use*; D014044:Tolbutamide / Q000494:pharmacology*; D016042:Transplantation, Heterotopic
D001786:Blood Glucose; D007328:Insulin; D016572:Cyclosporine; D014044:Tolbutamide; D005947:Glucose; D001379:Azathioprine; D011241:Prednisone